{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T02:10:18Z","timestamp":1758593418008,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neurol.2020.12.010","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T01:06:04Z","timestamp":1624323964000},"page":"1195-1198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fatal encephalopathy with brainstem involvement under dabrafenib and trametinib in a BRAF-positive metastatic melanoma"],"prefix":"10.1016","volume":"177","author":[{"given":"S.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maldonado-Slootjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2020.12.010_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1078155216638551","article-title":"Acute encephalopathy with combination dabrafenib\/trametinib therapy","volume":"23","author":"Cooper","year":"2017","journal-title":"J Oncol Pharm Practice"},{"issue":"6","key":"10.1016\/j.neurol.2020.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/1078155218790331","article-title":"Acute encephalopathy secondary to dabrafenib and trametinib in BRAF-positive metastatic adenocarcinoma of the lung","volume":"25","author":"Randhawa","year":"2019","journal-title":"J Oncol Pharm Practice"},{"issue":"2","key":"10.1016\/j.neurol.2020.12.010_bib0045","first-page":"136","article-title":"Clinical Letter: Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib following immunotherapy","volume":"18","author":"Stefanou","year":"2020","journal-title":"J German Soc Dermatol"},{"key":"10.1016\/j.neurol.2020.12.010_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2020.12.010_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you \u201ctake the brakes off\u201d the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.neurol.2020.12.010_bib0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/1759-7714.13266","article-title":"Clinical diagnosis and recommendations for immune checkpoint inhibitor-related adverse reactions in the nervous system","volume":"11","author":"Shi","year":"2020","journal-title":"Thorac Cancer"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721005592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721005592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:44:55Z","timestamp":1758519895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721005592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0035378721005592"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.12.010","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal encephalopathy with brainstem involvement under dabrafenib and trametinib in a BRAF-positive metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}